RxDoctor Payments Data

Jiyon Kim

Surgical · Massapequa, NYNPI 1942388061

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $9,190 of the $12,090 with a category attached, or 76.0%. It is spread thinly across 29 manufacturers, the largest accounting for just 23.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $4,185 and has fallen 71.7% since, to $1,184 in 2025. Among surgical clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,090in general payments, 2019–2025

Across 436 payments — averaging $27.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$3K
  • Johnson & Johnson$1K
  • AbbVie$1K
  • Sanofi$748
  • Amgen$653
  • Regeneron Healthcare Solutions, Inc.$614
  • plus $5K from 23 others

What the payments were for

  • Consulting fees$2502%
  • Speaking & faculty fees$2,25019%
  • Food & beverage$9,19076%
  • Education$4003%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,090 in reported general payments places this provider in the 95th percentile of 1,544 surgical providers in New York.

See all surgical providers in New York

Medicare billing

Part B allowed, 2024
$177,232
Medicare patients
244
Services billed
2,955

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab18$116,214
Clobetasol Propionate25$1,803
Triamcinolone Acetonide53$1,671
Clindamycin Phosphate13$885
Ketoconazole26$566
Mometasone Furoate21$444
Doxycycline Hyclate18$439
Ammonium Lactate19$330
Mupirocin43$304
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip14$299
Azithromycin19$71

Paid to pharmacies, not to this prescriber.

Other surgical in Massapequa

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →